Skip to content

The effect of plantago ointment on atopic dermatitis

The effect of plantago ointment on improving the symptoms of patients with atopic dermatitis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200304046695N1
Enrollment
48
Registered
2022-07-01
Start date
2022-07-23
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatit Atopic. Atopic dermatitis

Interventions

Intervention 1: Intervention group:First, the flowering plant is collected from Kerman Baft farms and after approval by a botanist, a herbarium sample is prepared. The collected plant is then dried in

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Approval of Hanifin and Rajka criteria for atopic dermatitis Mild to moderate atopic dermatitis (SCORAD <50) Poor response to conventional therapies (topical steroids and antihistamines) Absence of exudate or infection Concomitant presence of systemic disease or dermatitis except atopic dermatitis Written and informed consent of the patient

Exclusion criteria

Exclusion criteria: Taking oral or injectable steroids, antibiotics, phototherapy, and other immunosuppressive treatments (such as cyclosporine and azathioprine) but the corticosteroid position is not contraindicated. Day Symptoms of drug intolerance such as severe heartburn and bloating Existence of diseases that interfere with drug absorption, such as inflammatory bowel disease Inability to participate regularly in follow-up

Design outcomes

Primary

MeasureTime frame
Skin erythema. Timepoint: Before the intervention, 2 months after taking the drug, 15 days after the end of the course. Method of measurement: Based on scorad criteria.;Skin dryness. Timepoint: Before the intervention, 2 months after taking the drug, 15 days after the end of the course. Method of measurement: Based on scorad criteria.;Skin edema. Timepoint: Before the intervention, 2 months after taking the drug, 15 days after the end of the course. Method of measurement: Based on scorad criteria.;Skin itching. Timepoint: Before the intervention, 2 months after taking the drug, 15 days after the end of the course. Method of measurement: Based on scorad criteria.;Skin discharge. Timepoint: Before the intervention, 2 months after taking the drug, 15 days after the end of the course. Method of measurement: Based on scorad criteria.;Thickening of the skin. Timepoint: Before the intervention, 2 months after taking the drug, 15 days after the end of the course. Method of measurement: Based on scorad criteria.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZohreh Zandvakil

Kerman University of Medical Sciences

Zandvakilz@gmail.com+98 34 3132 5700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026